3 reports

This study covers the latent demand outlook for calcium channel blocker vasodilator pharmaceuticals across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent...

  • Calcium Channel Blocker
  • Pharmaceutical
  • India
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for calcium channel blocker vasodilator pharmaceuticals across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau),...

  • Calcium Channel Blocker
  • Pharmaceutical
  • China
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for calcium channel blocker vasodilator pharmaceuticals across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the...

  • Calcium Channel Blocker
  • Pharmaceutical
  • United States
  • Disposable Income
  • Purchasing Power Parity